Cargando…
Statins as a Therapeutic Approach for the Treatment of Pseudoxanthoma Elasticum Patients: Evaluation of the Spectrum Efficacy of Atorvastatin In Vitro
Pseudoxanthoma elasticum (PXE) is an autosomal recessive disorder caused by mutations in the ATP-binding cassette sub-family C member 6 gene. Our previous studies revealed that PXE might be associated with premature aging. Treatment with statins showed positive effects not only for PXE but also for...
Autores principales: | Tiemann, Janina, Lindenkamp, Christopher, Plümers, Ricarda, Faust, Isabel, Knabbe, Cornelius, Hendig, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923120/ https://www.ncbi.nlm.nih.gov/pubmed/33669724 http://dx.doi.org/10.3390/cells10020442 |
Ejemplares similares
-
Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum
por: Plümers, Ricarda, et al.
Publicado: (2023) -
Linking ABCC6 Deficiency in Primary Human Dermal Fibroblasts of PXE Patients to p21-Mediated Premature Cellular Senescence and the Development of a Proinflammatory Secretory Phenotype
por: Tiemann, Janina, et al.
Publicado: (2020) -
Cellular and Molecular Biomarkers Indicate Premature Aging in Pseudoxanthoma Elasticum Patients
por: Tiemann, Janina, et al.
Publicado: (2019) -
New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers
por: Hendig, Doris, et al.
Publicado: (2013) -
Large-Scaled Metabolic Profiling of Human Dermal Fibroblasts Derived from Pseudoxanthoma Elasticum Patients and Healthy Controls
por: Kuzaj, Patricia, et al.
Publicado: (2014)